procarbazine has been researched along with Germinoblastoma in 225 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multicenter phase II study was conducted to assess the efficacy of rituximab, methotrexate, procarbazine, and vincristine (R-MPV) followed by consolidation reduced-dose whole-brain radiotherapy (rdWBRT) and cytarabine in primary CNS lymphoma." | 9.17 | Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. ( Abrey, LE; Correa, DD; Curry, R; DeAngelis, LM; Grant, B; Grimm, S; Karimi, S; Lai, RK; Morris, PG; Omuro, A; Panageas, K; Raizer, JJ; Reiner, AS; Schiff, D; Shah, G; Yahalom, J, 2013) |
| "Forty-one patients receiving remission induction chemotherapy with vincristine, adriamycin and prednisolone (VAP) for high grade lymphoma or acute lymphoblastic leukaemia were entered into a double blind, placebo controlled trial of oral acyclovir prophylaxis against herpes simplex virus (HSV) infection." | 9.05 | Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial. ( Anderson, H; Brigden, D; Burke, C; Hickmott, E; Scarffe, JH; Sutton, RN, 1984) |
| "Lomustine, vincristine, procarbazine and prednisolone (LOPP) chemotherapy has been suggested to be an effective treatment for dogs with naïve non-indolent T-cell lymphoma (TCL)." | 8.12 | Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy. ( Blaxill, J; Buzzacott, P; Finlay, J, 2022) |
| "The optimal high-dose methotrexate (HDMTX)-based combination therapy for primary central nervous system lymphoma is unknown." | 8.12 | Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma. ( Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E, 2022) |
| "The aims of this study were to evaluate the safety of mustargen, vincristine, procarbazine and prednisone (MOPP) chemotherapy in the treatment of relapsed or refractory feline lymphoma, and to determine the overall response rate and median remission time with this protocol." | 7.96 | Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats. ( Brown, DC; Krick, EL; MaloneyHuss, MA; Mauldin, GE; Veluvolu, SM, 2020) |
| "This retrospective single-center study assessed the feasibility, outcomes, and side-effects of high-dose methotrexate (HD-MTX) plus procarbazine in the treatment of immunocompetent patients with primary central nervous system lymphoma (PCNSL)." | 7.81 | Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience. ( Hide, T; Kuratsu, J; Kuroda, J; Makino, K; Nakamura, H; Yano, S, 2015) |
| "The authors investigated objective response rate to high dose methotrexate (HDMTX)-based combination chemotherapy in primary central nervous system lymphoma (PCNSL), and sought to identify factors that influence response to HDMTX-based combination therapy." | 7.77 | Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma. ( Kim, YZ; Lee, EH; Sung, KH, 2011) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 7.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| "To assess the efficacy, acute toxicity, and delayed neurotoxicity of intermediate-dose methotrexate (MTX)-containing chemotherapy without whole-brain radiotherapy in the treatment of elderly patients with primary central nervous system lymphoma (PCNSL), we conducted a retrospective analysis of elderly patients (N = 17; median age 67) with newly diagnosed PCNSL who were treated with chemotherapy alone at Tsukuba University Hospital from January 2005 to December 2009." | 7.76 | A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma. ( Chiba, S; Hasegawa, Y; Matsumura, A; Okoshi, Y; Sakamoto, N; Takano, S; Taoka, K, 2010) |
| "Forty-one dogs with resistant lymphoma were treated with a modified MOPP (mechlorethamine, vincristine, procarbazine and prednisone) protocol (MPP [mechlorethamine, procarbazine and prednisone] administered on a 21-day cycle, shortened from the 28-day MOPP cycle)." | 7.75 | Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. ( Childress, MO; Gieger, TL; Hume, KR; Keys, DA; Kosarek, CE; LeRoy, BE; Northrup, NC; Saba, CF; Wall, TM, 2009) |
| "To assess the feasibility and the activity, as well as the efficacy to treat meninges, of chemotherapy (CHT) containing high-dose methotrexate (HD-MTX) followed by radiation therapy (RT), without intrathecal CHT, in patients with primary central nervous system lymphoma." | 7.71 | Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients. ( Bernardi, M; Camba, L; Ciceri, F; Dell'Oro, S; Ferreri, AJ; Ponzoni, M; Reni, M; Spina, M; Terreni, MR; Tomirotti, M; Villa, E, 2001) |
| "Twenty patients with refractory malignant lymphoma were treated with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) as salvage chemotherapy." | 7.67 | [Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma]. ( Goto, S; Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Nagura, E; Ninomiya, N; Ohnishi, K; Tsushita, K; Utsumi, M, 1989) |
| "Sixty-seven evaluable patients with mixed cellular and histiocytic lymphomas, both nodular and diffuse, were treated with a combined drug regimen of BCNU, cyclophosphamide, vincristine, and prednisone administered for six monthly courses." | 7.65 | 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma. ( Chan, YK; Dorfman, R; Durant, JR; Loeb, V, 1975) |
| "A total of 44 patients with Hodgkin's disease and 23 patients with non-Hodgkin malignant lymphoma were treated with MOPP-combination chemotherapy." | 5.26 | Procarbazine-induced skin reactions in Hodgkin's disease and other malignant lymphomas. ( Andersen, E; Videbaek, A, 1980) |
| "45%, respectively, in Hodgkin's disease, and 85% vs." | 5.25 | Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. ( Barros, CA; Morgenfeld, MC; Palau, M; Pavlovsky, A; Pavlovsky, S; Somoza, N; Suarez, A, 1975) |
| "A multicenter phase II study was conducted to assess the efficacy of rituximab, methotrexate, procarbazine, and vincristine (R-MPV) followed by consolidation reduced-dose whole-brain radiotherapy (rdWBRT) and cytarabine in primary CNS lymphoma." | 5.17 | Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. ( Abrey, LE; Correa, DD; Curry, R; DeAngelis, LM; Grant, B; Grimm, S; Karimi, S; Lai, RK; Morris, PG; Omuro, A; Panageas, K; Raizer, JJ; Reiner, AS; Schiff, D; Shah, G; Yahalom, J, 2013) |
| "Forty-one patients receiving remission induction chemotherapy with vincristine, adriamycin and prednisolone (VAP) for high grade lymphoma or acute lymphoblastic leukaemia were entered into a double blind, placebo controlled trial of oral acyclovir prophylaxis against herpes simplex virus (HSV) infection." | 5.05 | Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial. ( Anderson, H; Brigden, D; Burke, C; Hickmott, E; Scarffe, JH; Sutton, RN, 1984) |
| "Fifty-two patients with stage III or IV nodular mixed lymphocytic-histiocytic lymphoma (NM) were entered on a prospective randomized trial comparing cyclophosphamide-prednisone (CP) to either COPP (cyclophosphamide, vincristine, procarbazine, prednisone) or BCVP (BCNU, cyclophosphamide, vincristine, prednisone)." | 5.05 | Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. ( Barnes, JM; Bennett, JM; Berard, CW; Ezdinli, EZ; Glick, JH; Orlow, EL, 1981) |
| " protocol consisting of: vincristine-prednisone plus surgery and/or radiotherapy as induction treatment, craniocervical radiotherapy and intrathecal methotrexate as CNS preventive treatment and anti-leukemia (6-mercaptopurine, methotrexate and vincristine-prednisone pulses) or anti-lymphoma (COPP) treatment as maintenance, in a randomized trial." | 5.04 | Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina. ( Cebrian-Bonesana, A; Kvicala, R; Lein, JM; Ojeda, FG; Pavlovsky, S; Penchansky, L; Pependieck, C; Roca-Garcia, C; Sackmann-Muriel, S; Schvartzman, E, 1978) |
| " The risk of treatment-induced acute leukemias as well as sterility can be avoided or greatly decreased with drug combinations not including procarbazine HCI and alkylating agents." | 4.77 | Chemotherapy of malignant lymphomas. ( Bonadonna, G, 1985) |
| "The optimal high-dose methotrexate (HDMTX)-based combination therapy for primary central nervous system lymphoma is unknown." | 4.12 | Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma. ( Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E, 2022) |
| "Lomustine, vincristine, procarbazine and prednisolone (LOPP) chemotherapy has been suggested to be an effective treatment for dogs with naïve non-indolent T-cell lymphoma (TCL)." | 4.12 | Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy. ( Blaxill, J; Buzzacott, P; Finlay, J, 2022) |
| "The aims of this study were to evaluate the safety of mustargen, vincristine, procarbazine and prednisone (MOPP) chemotherapy in the treatment of relapsed or refractory feline lymphoma, and to determine the overall response rate and median remission time with this protocol." | 3.96 | Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats. ( Brown, DC; Krick, EL; MaloneyHuss, MA; Mauldin, GE; Veluvolu, SM, 2020) |
| "To analyze the efficacy of cyclophosphamideplus, epirubicin, vincristine, prednisone plus etoposide and/or bleomycin, with or without rituximab (R±BEACOP) regimen in patient with poor-prognosis lymphoma." | 3.81 | [Efficacy of R±BEACOP regimen in patients with poor-prognosis lymphoma]. ( Dong, F; Ke, X; Pang, Y; Wang, J, 2015) |
| "This retrospective single-center study assessed the feasibility, outcomes, and side-effects of high-dose methotrexate (HD-MTX) plus procarbazine in the treatment of immunocompetent patients with primary central nervous system lymphoma (PCNSL)." | 3.81 | Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience. ( Hide, T; Kuratsu, J; Kuroda, J; Makino, K; Nakamura, H; Yano, S, 2015) |
| "A retrospective chart review of lymphoma patients who were treated with both procarbazine and an antidepressant, as well as procarbazine alone, was performed to determine if signs and symptoms of serotonin toxicity were present." | 3.80 | Procarbazine and antidepressants: a retrospective review of the risk of serotonin toxicity. ( Baker, NM; Bostwick, JR; Carpenter, J; Kraft, SL, 2014) |
| "To determine if the oral PEP-C regimen, consisting of prednisone 20 mgm, etoposide 50 mgm, procarbazine 50 mgm, and cyclophosphamide 50 mgm given in either a daily, alternate day, or fractionated basis, is effective in a variety of lymphomas." | 3.78 | Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen. ( Coleman, M; Elstrom, RL; Leonard, JP; Martin, P; Ruan, G, 2012) |
| "The authors investigated objective response rate to high dose methotrexate (HDMTX)-based combination chemotherapy in primary central nervous system lymphoma (PCNSL), and sought to identify factors that influence response to HDMTX-based combination therapy." | 3.77 | Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma. ( Kim, YZ; Lee, EH; Sung, KH, 2011) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 3.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| "To assess the efficacy, acute toxicity, and delayed neurotoxicity of intermediate-dose methotrexate (MTX)-containing chemotherapy without whole-brain radiotherapy in the treatment of elderly patients with primary central nervous system lymphoma (PCNSL), we conducted a retrospective analysis of elderly patients (N = 17; median age 67) with newly diagnosed PCNSL who were treated with chemotherapy alone at Tsukuba University Hospital from January 2005 to December 2009." | 3.76 | A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma. ( Chiba, S; Hasegawa, Y; Matsumura, A; Okoshi, Y; Sakamoto, N; Takano, S; Taoka, K, 2010) |
| "Forty-one dogs with resistant lymphoma were treated with a modified MOPP (mechlorethamine, vincristine, procarbazine and prednisone) protocol (MPP [mechlorethamine, procarbazine and prednisone] administered on a 21-day cycle, shortened from the 28-day MOPP cycle)." | 3.75 | Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. ( Childress, MO; Gieger, TL; Hume, KR; Keys, DA; Kosarek, CE; LeRoy, BE; Northrup, NC; Saba, CF; Wall, TM, 2009) |
| "Our goals were to evaluate the safety of adding rituximab to methotrexate (MTX)-based chemotherapy for primary CNS lymphoma, determine whether additional cycles of induction chemotherapy improve the complete response (CR) rate, and examine effectiveness and toxicity of reduced-dose whole-brain radiotherapy (WBRT) after CR." | 3.74 | Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. ( Abrey, LE; Correa, DD; DeAngelis, LM; Grant, B; Lai, RK; LaRocca, R; Raizer, JJ; Schiff, D; Shah, GD; Yahalom, J, 2007) |
| "In the histiocytic lymphomas, BCNU added to CVP increases the percentage of CRs but it does so at the expense of considerable toxicity." | 3.74 | Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience. ( Bennett, JM; Carbone, PP; Ezdinli, E; Johnson, GJ; Lenhard, RE; Pocock, SJ, 1977) |
| "To assess the feasibility and the activity, as well as the efficacy to treat meninges, of chemotherapy (CHT) containing high-dose methotrexate (HD-MTX) followed by radiation therapy (RT), without intrathecal CHT, in patients with primary central nervous system lymphoma." | 3.71 | Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients. ( Bernardi, M; Camba, L; Ciceri, F; Dell'Oro, S; Ferreri, AJ; Ponzoni, M; Reni, M; Spina, M; Terreni, MR; Tomirotti, M; Villa, E, 2001) |
| "Twelve patients with relapsed or refractory malignant lymphoma were treated with IMV-triple P regimen consisting of ifosfamide (IFM), mitoxantrone (MIT), vindesine (VDS), pepleomycin (PEP), procarbazine (PCZ) and prednisolone (PDN)." | 3.68 | [Salvage chemotherapy with IMV-triple P for relapsed or refractory malignant lymphoma]. ( Arai, N; Hara, A; Shirai, T; Umeda, M, 1991) |
| "Fifty-one patients with diffuse large-cell lymphoma (DLCL) were treated with a six-drug combination chemotherapy regimen including cyclophosphamide, doxorubicin, procarbazine, bleomycin, vincristine, and prednisone." | 3.67 | Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. ( Armitage, JO; Dowling, M; Howe, D; Hutchins, M; Johnson, PS; Mailliard, J; Moravec, DF; Okerbloom, J; Sorensen, S; Weisenburger, DD, 1986) |
| "Twenty patients with refractory malignant lymphoma were treated with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) as salvage chemotherapy." | 3.67 | [Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma]. ( Goto, S; Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Nagura, E; Ninomiya, N; Ohnishi, K; Tsushita, K; Utsumi, M, 1989) |
| "COPBLAM III, a polychemotherapy regimen consisting of cyclophosphamide, infusional vincristine, prednisone, infusional bleomycin, doxorubicin, and procarbazine, was administered to 51 patients with diffuse large-cell lymphoma." | 3.67 | COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma. ( Bernhardt, B; Boyd, DB; Coleman, M; Files, JC; Gaynor, M; Kopel, SK; McDermott, D; Papish, SW; Schwartz, S; Topilow, A, 1988) |
| "Ninety-five patients with advanced non-Hodgkin's lymphoma were treated with four courses of cyclophosphamide, adriamycin, vincristine and prednisone, with or without procarbazine [CHOP(P)] chemotherapy; either 150 rad total body irradiation (for "extensive" disease) or 3,500 rad local radiation therapy (for "limited" disease); and a final four courses of CHOP(P) chemotherapy." | 3.66 | Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients. ( Appelbaum, FR; Bagley, CM; Dahlberg, S; Farewell, VT; Kadin, ME; Neiman, PE; Rudolph, RH; Sullivan, KM; Thomas, ED, 1983) |
| "The paper deals with a comparison of the results of treatment of 19 patients with malignant lymphomas, mostly diffuse ones, stage 3, by POPP schedule (paphencyl, vincristine (oncovine), procarbosin (natulan) and prednisolone) and 37 similar patients who received a modified standard COPP treatment." | 3.66 | [Therapeutic results in malignant lymphomas treated by the COPP and POPP drug administration schedules]. ( Bliumental', RIa; Iavorkovskiĭ, LI; Rotsena, AIa; Udris, OIu; Zile, MA, 1981) |
| "Sixty-seven evaluable patients with mixed cellular and histiocytic lymphomas, both nodular and diffuse, were treated with a combined drug regimen of BCNU, cyclophosphamide, vincristine, and prednisone administered for six monthly courses." | 3.65 | 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma. ( Chan, YK; Dorfman, R; Durant, JR; Loeb, V, 1975) |
| " Seventeen patients with Hodgkin's disease and 15 with non-Hodgkin's lymphoma were subjected to nontherapeutic splenectomy as part of the staging procedure prior to their initial treatment with MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) or CVP (cyclophosphamide, vincristine, and prednisone) chemotherapy, respectively." | 3.65 | Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. ( Canellos, GP; DeVita, VT; Ihde, DC; Young, RC, 1976) |
| "Four adult patients with malignant lymphoma were treated with combination chemotherapy including an alkylating agent, vincristine, procarbazine (in all but one case), and intermittent high-dose prednisone." | 3.65 | Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids). ( DeVita, VT; Ihde, DC, 1975) |
| "Four patients with malignant lymphoma who were treated with multiple courses of combination chemotherapy, consisting of cyclophosphamide, Oncovin, procarbazine, and prednisone (COPP), developed avascular necrosis of the femoral head(s)." | 3.65 | Avascular necrosis of the femoral head with combination therapy. ( Desser, RK; Miller, JB; Roth, DG; Sweet, DL; Ultmann, JE, 1976) |
| " A comparison of drug dosage in the group receiving TPN and the group receiving standard nutrition is a measure of drug tolerance in these patients." | 2.65 | A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance. ( Brennan, MF; Fisher, RI; Popp, MB; Simon, RM, 1981) |
| "The response rate and survival in diffuse histiocytic lymphoma have improved since the first study." | 2.64 | Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group. ( Coltman, CA; Jones, SE; Luce, JK; McKelvey, EM; Moon, TE, 1977) |
| " This side effect could be explained by a cycling of the hematopoietic stem-cells and call to some caution when androgens are used during cancer chemotherapy." | 2.64 | [Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)]. ( Barthélémy, M; Bilski-Pasquier, G; Blanc, CM; Bouchard, M; Bousser, J; Zittoun, R, 1977) |
| "Similarly, the International Non-Hodgkin's Lymphoma Prognostic Factors Project proposed a new predictive model for survival of aggressive lymphoma patients." | 2.39 | [Recent progress in the chemotherapy of malignant lymphoma]. ( Tobinai, K, 1995) |
| "Chemotherapy of malignant lymphomas has accomplished a significant progress during the two decades." | 2.38 | [Current status of chemotherapy in the treatment of malignant lymphomas]. ( Hayashi, K; Kimura, I; Mizuta, J; Murashima, M; Ohnoshi, T; Tada, A; Tagawa, S; Ueno, K, 1989) |
| "Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches." | 2.37 | Early-stage Hodgkin's disease: current approaches to treatment. ( MacKenzie, R; Rusthoven, JJ, 1985) |
| "Hodgkin's disease is treated according to stage, histology and other prognostic criteria and the appropriate management is presented in tabular form." | 2.36 | [Therapy of malignant lymphomas]. ( Braunsteiner, H; Brittinger, G; Frommhold, H; Gattringer, C; Gyenes, T; Huber, H; Lechleitner, M, 1983) |
| "The median value of Inhibin B in the cancer survivor group was 126 ng/L versus 177 ng/L in the control group (P < 0." | 1.35 | Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. ( Dohle, GR; Hählen, K; Hakvoort-Cammel, FG; van Casteren, NJ; van den Heuvel-Eibrink, MM; van der Linden, GH, 2009) |
| "Patients treated for Hodgkin's disease and non-Hodgkin lymphomas were followed for 5 years after start of therapy." | 1.30 | Five-year follow-up of saliva in patients treated for lymphomas. ( Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L, 1997) |
| "Subsequently, standard chemotherapy for Hodgkin's disease induced complete clinical and biochemical remission." | 1.29 | Suspected malignant lymphoma presenting with widespread granulomatous lesions in bones and lymph nodes and responding to combination chemotherapy. ( Jensen, MK; Johansen, P; Pulczynski, S, 1996) |
| "Primary malignant lymphoma localized in the uterine cervix is a rare condition for which radiation therapy, surgery, or chemotherapy either alone or in combination have been the mainstay of treatment." | 1.29 | Primary malignant lymphoma of the uterine cervix shows favorable response to neoadjuvant chemotherapy. ( Chang, CH; Chou, CY; Huang, KE; Kuo, HC; Liu, MT; Tzeng, CC, 1994) |
| "Its occurrence in malignant lymphoma has not been reported heretofore." | 1.28 | Pneumothorax following cytotoxic chemotherapy in malignant lymphoma. ( Chang, SC; Hsu, JR; Perng, RP, 1990) |
| "In 1984, the complete remission of malignant lymphoma was observed after MOPP, COPP and VAPP chemotherapies." | 1.28 | [Secondary leukemia (AML) with TcR beta rearrangement]. ( Akiyoshi, T; Hisano, S; Ishibashi, M; Kawara, T; Kikuchi, M; Kimura, N; Kyoshoin, K; Morioka, E; Okumura, M, 1989) |
| "Biopsy specimen revealed malignant lymphoma." | 1.28 | [Triple malignancy including bladder carcinoma, prostate carcinoma and malignant lymphoma: a case report]. ( Kobayashi, Y; Kuyama, J; Matsuda, M; Miyagawa, M; Ohnishi, S; Oritani, K; Tada, Y; Yasunaga, Y; Yoshioka, T, 1989) |
| "12 patients with brain tumors were treated with a combination of procarbazine, CCNU (bis-2-chloroethyl-3-cyclohexyl-1-nitrosourea) and vincristine." | 1.27 | Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors. ( Biran, S; Brufman, G; Catane, R; Halpern, J; Sulkes, A, 1984) |
| "A strategy for treatment of malignant lymphoma requires fundamentally a field of multidisciplinary treatment including mainly radiotherapy and chemotherapy in a collaboration with surgical procedure and immunotherapeutic maneuver." | 1.27 | [Malignant lymphoma]. ( Kita, K; Shirakawa, S; Tanaka, I, 1985) |
| "Thirty-four subsequent second malignant neoplasms were observed in 33 patients among those treated for Hodgkin's disease." | 1.27 | Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. ( DeVita, VT; Glatstein, E; Kelley, PA; Kinsella, TJ; Makuch, RW; Tester, WJ; Waller, B, 1984) |
| "A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP." | 1.27 | Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease. ( Eridani, S; Singh, AK, 1986) |
| "In addition, acute renal failure developed in both patients, and myolysis in one." | 1.27 | Purpura fulminans in pneumococcal sepsis. ( Berneman, ZN; Bieger, R; Bridts, C; Buyssens, N; Hautekeete, ML; Peetermans, ME; Stevens, WJ, 1986) |
| "Thirty-four patients with Hodgkin's disease and non-Hodgkin's lymphoma underwent therapeutic splenectomies to improve hematologic tolerance for chemotherapy." | 1.27 | The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas. ( Cox, RS; Hoppe, RT; Jacobs, C; Rosenberg, SA; Schreiber, DP, 1985) |
| "Diagnosis and therapy of malignant lymphoma of the skin were reviewed." | 1.27 | [Malignant lymphoma of the skin]. ( Miyamoto, H; Nakajima, H, 1985) |
| "In three patients with malignant lymphoma who received 0." | 1.26 | Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion. ( Kuhlmann, J; Rietbrock, N; Wilke, J, 1982) |
| " Aclacinomycin-A showed no treatment schedule dependency in this tumor system and the optimal dosage of this drug was twice higher than that of adriamycin on each treatment schedule; i." | 1.26 | Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system. ( Fujimoto, S; Horikoshi, N; Inagaki, J; Ogawa, M, 1979) |
| "For patients with lymphosarcoma the average duration of complete remission was 26." | 1.26 | [Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)]. ( Hiller, E; Schmülling, RM; Tigges, FJ; Waller, HD; Wilms, K, 1977) |
| "Nausea was usually precipitated by the odor of the clinic and similar odors elsewhere also caused nausea." | 1.26 | Pretreatment nausea in cancer chemotherapy: a conditioned response? ( Carli, T; Curtis, GC; Kleinman, PD; Nesse, RM, 1980) |
| "Nine patients with aplastic anemia rejected their first graft." | 1.26 | Experience with second marrow transplants. ( Buckner, CD; Clift, RA; Fefer, A; Neiman, PE; Storb, R; Thomas, ED; Wright, SE, 1976) |
| "86 patients with advanced malignant lymphomas (stage III and IV) were treated either with Vinblastine given as a single agent (49 cases) or with combination chemotherapy MOPP or COP (37 cases)." | 1.26 | Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy. ( Donner, L; Klener, P; Roth, Z, 1976) |
| "Because nonrandom acquired clonal chromosome abnormalities are a consistent feature of malignancies, our data suggest that AILD may be a malignant disease despite its original description as a benign proliferative process." | 1.26 | Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. ( Haren, JM; Kaneko, Y; Larson, RA; Rowley, JD; Variakojis, D, 1982) |
| "A total of 44 patients with Hodgkin's disease and 23 patients with non-Hodgkin malignant lymphoma were treated with MOPP-combination chemotherapy." | 1.26 | Procarbazine-induced skin reactions in Hodgkin's disease and other malignant lymphomas. ( Andersen, E; Videbaek, A, 1980) |
| "15 patients with malignant lymphomas (stage III B or IV) who had become resistant to previous combination chemotherapy were treated with DTIC." | 1.26 | Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations. ( Donner, L; Klener, P, 1977) |
| "45%, respectively, in Hodgkin's disease, and 85% vs." | 1.25 | Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. ( Barros, CA; Morgenfeld, MC; Palau, M; Pavlovsky, A; Pavlovsky, S; Somoza, N; Suarez, A, 1975) |
| "Patients with diffuse histiocytic lymphoma who achieved a complete remission after 6 months of treatment without maintenance have remained disease-free, whereas those with nodular poorly differentiated lymphocytic and diffuse well differentiated lymphocytic lymphomata demonstrate a pattern of continuous late recurrence." | 1.25 | Results of combination chemotherapy of non-Hodgkin's lymphoma. ( Berard, C; Canellos, GP; Chabner, BA; DeVita, VT; Schein, PS; Young, RD, 1975) |
| "Azathioprine was best tolerated, but gave only medium results whereas procarbazine, as a very potent drug, had the highest rate of side effects (especially depression of bone marrow, infections, gastrointestinal manifestations etc." | 1.25 | [Side effects in immunosuppressive therapy]. ( Thumb, N, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 162 (72.00) | 18.7374 |
| 1990's | 19 (8.44) | 18.2507 |
| 2000's | 18 (8.00) | 29.6817 |
| 2010's | 19 (8.44) | 24.3611 |
| 2020's | 7 (3.11) | 2.80 |
| Authors | Studies |
|---|---|
| Blaxill, J | 1 |
| Buzzacott, P | 1 |
| Finlay, J | 1 |
| O'Connell, K | 1 |
| Thomson, M | 1 |
| Morgan, E | 1 |
| Henning, J | 1 |
| Lebel, E | 1 |
| Goldschmidt, N | 1 |
| Siegal, T | 1 |
| Lossos, A | 1 |
| Rosenberg, S | 1 |
| Makranz, C | 1 |
| Linetski, E | 1 |
| Gatt, ME | 1 |
| Gural, A | 1 |
| Saban, R | 1 |
| Lavie, D | 1 |
| Vainstein, V | 1 |
| Zimran, E | 1 |
| Avni, B | 1 |
| Grisaro, S | 1 |
| Shaulov, A | 1 |
| Nachmias, B | 1 |
| Wirdah, A | 1 |
| Djamaludin, N | 1 |
| Syahrir, M | 1 |
| Andayani, YD | 1 |
| Andriani, M | 1 |
| Diansari, Y | 1 |
| Zimmerman, K | 1 |
| Walsh, KA | 1 |
| Ferrari, JT | 1 |
| Keuler, NS | 1 |
| Atherton, MJ | 1 |
| Lenz, JA | 1 |
| Isbell, LK | 1 |
| Uibeleisen, R | 1 |
| Friedl, A | 1 |
| Burger, E | 1 |
| Dopatka, T | 1 |
| Scherer, F | 1 |
| Orban, A | 1 |
| Lauer, E | 1 |
| Malenica, N | 1 |
| Semenova, I | 1 |
| Vreden, A | 1 |
| Valk, E | 1 |
| Wendler, J | 1 |
| Neumaier, S | 1 |
| Fricker, H | 1 |
| El Rabih, AAH | 1 |
| Gloggengießer, C | 1 |
| Hilbig, D | 1 |
| Bleul, S | 1 |
| Weis, J | 1 |
| Gmehlin, D | 1 |
| Backenstrass, M | 1 |
| Wirtz, S | 1 |
| Ihorst, G | 1 |
| Finke, J | 1 |
| Illerhaus, G | 1 |
| Schorb, E | 1 |
| Hattori, K | 1 |
| Sakata-Yanagimoto, M | 1 |
| Okoshi, Y | 2 |
| Kato, T | 1 |
| Kurita, N | 1 |
| Yokoyama, Y | 1 |
| Obara, N | 1 |
| Takano, S | 2 |
| Ishikawa, E | 1 |
| Yamamoto, T | 1 |
| Matsumura, A | 2 |
| Hasegawa, Y | 2 |
| Chiba, S | 2 |
| MaloneyHuss, MA | 1 |
| Mauldin, GE | 1 |
| Brown, DC | 1 |
| Veluvolu, SM | 1 |
| Krick, EL | 1 |
| Bozdağ, SC | 1 |
| Tekgündüz, E | 1 |
| Durgun, G | 1 |
| Sarıca, A | 1 |
| Demiriz, IŞ | 1 |
| Koçubaba, S | 1 |
| Altuntaş, F | 1 |
| Kim, YR | 1 |
| Kim, SH | 1 |
| Chang, JH | 1 |
| Suh, CO | 1 |
| Kim, SJ | 1 |
| Kim, Y | 1 |
| Hwang, DY | 1 |
| Jang, JE | 1 |
| Hyun, SY | 1 |
| Cheong, JW | 1 |
| Min, YH | 1 |
| Kim, JS | 1 |
| Kraft, SL | 1 |
| Baker, NM | 1 |
| Carpenter, J | 1 |
| Bostwick, JR | 1 |
| Morris, PG | 1 |
| Correa, DD | 2 |
| Yahalom, J | 3 |
| Raizer, JJ | 2 |
| Schiff, D | 2 |
| Grant, B | 2 |
| Grimm, S | 1 |
| Lai, RK | 2 |
| Reiner, AS | 1 |
| Panageas, K | 1 |
| Karimi, S | 1 |
| Curry, R | 1 |
| Shah, G | 1 |
| Abrey, LE | 3 |
| DeAngelis, LM | 5 |
| Omuro, A | 4 |
| Makino, K | 1 |
| Nakamura, H | 1 |
| Hide, T | 1 |
| Kuroda, J | 1 |
| Yano, S | 1 |
| Kuratsu, J | 1 |
| Zietman, AL | 1 |
| Dong, F | 1 |
| Pang, Y | 1 |
| Wang, J | 1 |
| Ke, X | 1 |
| Chinot, O | 2 |
| Taillandier, L | 2 |
| Ghesquieres, H | 1 |
| Soussain, C | 3 |
| Delwail, V | 1 |
| Lamy, T | 1 |
| Gressin, R | 1 |
| Choquet, S | 3 |
| Soubeyran, P | 2 |
| Huchet, A | 1 |
| Benouaich-Amiel, A | 1 |
| Lebouvier-Sadot, S | 1 |
| Gyan, E | 1 |
| Touitou, V | 2 |
| Barrié, M | 1 |
| del Rio, MS | 1 |
| Gonzalez-Aguilar, A | 2 |
| Houillier, C | 3 |
| Delgadillo, D | 1 |
| Lacomblez, L | 1 |
| Tanguy, ML | 1 |
| Hoang-Xuan, K | 4 |
| Avagyan, A | 1 |
| Danielyan, S | 1 |
| Voskanyan, A | 1 |
| Sargsyan, L | 1 |
| Hakobyan, L | 1 |
| Zohrabyan, D | 1 |
| Safaryan, L | 1 |
| Harutyunyan, L | 1 |
| Bardakchyan, S | 1 |
| Iskanyan, S | 1 |
| Arakelyan, S | 1 |
| Tamamyan, G | 1 |
| Nguyen, DT | 1 |
| Cassoux, N | 1 |
| Le Cossec, C | 1 |
| Legarf-Tavernier, M | 1 |
| Costopoulos, M | 1 |
| LeHoang, P | 1 |
| Bodaghi, B | 1 |
| van Casteren, NJ | 1 |
| van der Linden, GH | 1 |
| Hakvoort-Cammel, FG | 1 |
| Hählen, K | 1 |
| Dohle, GR | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Northrup, NC | 1 |
| Gieger, TL | 1 |
| Kosarek, CE | 1 |
| Saba, CF | 1 |
| LeRoy, BE | 1 |
| Wall, TM | 1 |
| Hume, KR | 1 |
| Childress, MO | 1 |
| Keys, DA | 1 |
| Ferreri, AJ | 2 |
| Verona, C | 1 |
| Politi, LS | 1 |
| Chiara, A | 1 |
| Perna, L | 1 |
| Villa, E | 2 |
| Reni, M | 2 |
| Taoka, K | 2 |
| Sakamoto, N | 1 |
| Rassnick, KM | 1 |
| Bailey, DB | 1 |
| Malone, EK | 1 |
| Intile, JL | 1 |
| Kiselow, MA | 1 |
| Flory, AB | 1 |
| Barlow, LL | 1 |
| Balkman, CE | 1 |
| Barnard, SM | 1 |
| Waite, AH | 1 |
| Sung, KH | 1 |
| Lee, EH | 1 |
| Kim, YZ | 1 |
| Sierra Del Rio, M | 1 |
| Ricard, D | 1 |
| Navarro, S | 1 |
| Idbaih, A | 1 |
| Kaloshi, G | 1 |
| Elhallani, S | 1 |
| Fahey, CE | 1 |
| Milner, RJ | 1 |
| Barabas, K | 1 |
| Lurie, D | 1 |
| Kow, K | 1 |
| Parfitt, S | 1 |
| Lyles, S | 1 |
| Clemente, M | 1 |
| Yamamoto, G | 1 |
| Kaburaki, T | 1 |
| Takahashi, T | 1 |
| Araie, M | 1 |
| Kurokawa, M | 1 |
| Coleman, M | 4 |
| Ruan, G | 1 |
| Elstrom, RL | 1 |
| Martin, P | 2 |
| Leonard, JP | 2 |
| Metayer, C | 1 |
| Curtis, RE | 1 |
| Vose, J | 1 |
| Sobocinski, KA | 1 |
| Horowitz, MM | 1 |
| Bhatia, S | 1 |
| Fay, JW | 1 |
| Freytes, CO | 1 |
| Goldstein, SC | 1 |
| Herzig, RH | 1 |
| Keating, A | 1 |
| Miller, CB | 1 |
| Nevill, TJ | 1 |
| Pecora, AL | 1 |
| Rizzo, JD | 1 |
| Williams, SF | 1 |
| Li, CY | 1 |
| Travis, LB | 1 |
| Weisdorf, DJ | 1 |
| Seiferheld, W | 2 |
| Schold, SC | 2 |
| Fisher, B | 2 |
| Schultz, CJ | 1 |
| Bogdhan, U | 1 |
| Hildebrand, J | 1 |
| Frenay, M | 1 |
| De Beule, N | 1 |
| Delattre, JY | 2 |
| Baron, B | 1 |
| BERUMEN, L | 1 |
| GUEVARA, GF | 1 |
| TODD, ID | 2 |
| BEGEMANN, H | 1 |
| BLUM, KU | 1 |
| FELLMER, KE | 1 |
| FOELSCH, E | 1 |
| GERHARTZ, H | 1 |
| GRUNZE, H | 1 |
| HAUSMANN, K | 1 |
| HENNES, R | 1 |
| JUENGLING, W | 1 |
| KLEIBEL, F | 1 |
| KOERTGE, P | 1 |
| MARING, H | 1 |
| MARTIN, H | 1 |
| OBRECHT, P | 1 |
| OSTEN, W | 1 |
| PABST, HW | 1 |
| POLIWODA, H | 1 |
| SCHUBERT, JC | 1 |
| SEIDL, S | 1 |
| SPECHTER, HJ | 1 |
| STRICKSTROCK, KH | 1 |
| WITTE, S | 1 |
| DREWS, J | 1 |
| Korfel, A | 1 |
| Martus, P | 1 |
| Nowrousian, MR | 1 |
| Hossfeld, DK | 1 |
| Kirchen, H | 1 |
| Brücher, J | 1 |
| Stelljes, M | 1 |
| Birkmann, J | 1 |
| Peschel, C | 1 |
| Pasold, R | 1 |
| Fischer, L | 1 |
| Jahnke, K | 1 |
| Thiel, E | 2 |
| Omuro, AM | 1 |
| Yamanaka, R | 4 |
| Morii, K | 3 |
| Shinbo, Y | 4 |
| Takeuchi, S | 1 |
| Tamura, T | 3 |
| Hondoh, H | 3 |
| Takahashi, H | 4 |
| Onda, K | 3 |
| Tanaka, R | 4 |
| Schultz, C | 1 |
| DeAngelis, L | 1 |
| Nelson, D | 1 |
| Curran, W | 1 |
| Mehta, M | 1 |
| Björkholm, M | 1 |
| Celsing, F | 1 |
| Johansson, E | 1 |
| Homma, J | 3 |
| Sano, M | 3 |
| Tsuchiya, N | 3 |
| Yajima, N | 3 |
| Hasegawa, A | 1 |
| Shah, GD | 1 |
| LaRocca, R | 1 |
| Ruan, J | 1 |
| Furman, R | 1 |
| Niesvizky, R | 1 |
| Elstrom, R | 1 |
| George, P | 1 |
| Kaufman, TP | 1 |
| Kakuma, T | 1 |
| Neuwelt, EA | 2 |
| Hill, SA | 1 |
| Frenkel, EP | 1 |
| Klener, P | 3 |
| Donner, L | 3 |
| Portlock, CS | 3 |
| Rupniewska, ZM | 1 |
| Kurowska, M | 1 |
| Klastersky, J | 1 |
| Kaneko, Y | 1 |
| Larson, RA | 1 |
| Variakojis, D | 1 |
| Haren, JM | 1 |
| Rowley, JD | 1 |
| Płuzańska, A | 1 |
| Krykowski, E | 1 |
| Robak, T | 1 |
| Oliskiewicz, W | 1 |
| Polkowska, E | 1 |
| Dowgier, I | 1 |
| Hyjek, E | 1 |
| Bartels, H | 1 |
| Schneider, B | 1 |
| Feller, AC | 1 |
| Freireich, EJ | 2 |
| Keating, M | 1 |
| Cabanillas, F | 1 |
| Barlogie, B | 1 |
| Kasahara, M | 1 |
| Mizoguchi, Y | 1 |
| Kuroda, M | 1 |
| Miki, Y | 1 |
| Yamamoto, N | 1 |
| Horibe, Y | 1 |
| Fujita, K | 1 |
| Watanabe, H | 1 |
| Hondo, R | 1 |
| Aoyama, U | 1 |
| Huber, H | 1 |
| Gattringer, C | 1 |
| Lechleitner, M | 1 |
| Gyenes, T | 1 |
| Frommhold, H | 1 |
| Brittinger, G | 1 |
| Braunsteiner, H | 1 |
| Sullivan, KM | 1 |
| Neiman, PE | 2 |
| Kadin, ME | 1 |
| Dahlberg, S | 1 |
| Farewell, VT | 1 |
| Rudolph, RH | 1 |
| Bagley, CM | 2 |
| Appelbaum, FR | 1 |
| Thomas, ED | 2 |
| Jacquillat, C | 1 |
| Khayat, D | 1 |
| Desprez-Curely, JP | 1 |
| Weil, M | 1 |
| Brocheriou, C | 1 |
| Auclerc, G | 1 |
| Chamseddine, N | 1 |
| Bernard, J | 1 |
| Anderson, H | 1 |
| Scarffe, JH | 2 |
| Sutton, RN | 1 |
| Hickmott, E | 1 |
| Brigden, D | 1 |
| Burke, C | 1 |
| Brufman, G | 1 |
| Halpern, J | 1 |
| Sulkes, A | 1 |
| Catane, R | 1 |
| Biran, S | 1 |
| Voltarelli, JC | 1 |
| Falcão, RP | 1 |
| Bottura, C | 1 |
| Tester, WJ | 1 |
| Kinsella, TJ | 2 |
| Waller, B | 1 |
| Makuch, RW | 1 |
| Kelley, PA | 1 |
| Glatstein, E | 2 |
| DeVita, VT | 12 |
| Sampi, K | 2 |
| Honda, T | 2 |
| Hattori, M | 2 |
| Leung, AC | 1 |
| McKean, M | 1 |
| Mactier, R | 1 |
| Dobbie, JW | 1 |
| Mead, GM | 1 |
| Macbeth, FR | 1 |
| Williams, CJ | 1 |
| Ryall, RD | 1 |
| Wright, DH | 1 |
| Whitehouse, JM | 1 |
| Heinz, R | 2 |
| Hanak, H | 2 |
| Shimizu, Y | 1 |
| Hashida, T | 1 |
| Esumi, N | 1 |
| Morioka, Y | 1 |
| Nagai, T | 1 |
| Arakawa, S | 1 |
| Imashuku, S | 1 |
| Fushiki, S | 1 |
| Ikuta, H | 1 |
| Miyake, M | 1 |
| Fisher, RI | 5 |
| Hubbard, SM | 3 |
| Longo, DL | 3 |
| Wesley, R | 1 |
| Chabner, BA | 5 |
| Young, RC | 7 |
| Mandelli, F | 1 |
| Biagini, C | 1 |
| Baroni, CD | 1 |
| Bosman, C | 1 |
| Anselmo, AP | 1 |
| de Luca, AM | 1 |
| Granati, L | 1 |
| Petti, N | 1 |
| Papa, G | 1 |
| Schoengen, A | 1 |
| Popp, MB | 1 |
| Simon, RM | 1 |
| Brennan, MF | 1 |
| Nesse, RM | 1 |
| Carli, T | 1 |
| Curtis, GC | 1 |
| Kleinman, PD | 1 |
| Kantor, G | 1 |
| Cosset, JM | 1 |
| Masselot, J | 1 |
| Kuhlmann, J | 1 |
| Wilke, J | 1 |
| Rietbrock, N | 1 |
| Iavorkovskiĭ, LI | 1 |
| Rotsena, AIa | 1 |
| Udris, OIu | 1 |
| Bliumental', RIa | 1 |
| Zile, MA | 1 |
| Horikoshi, N | 2 |
| Ogawa, M | 3 |
| Streuli, RA | 1 |
| Glick, JH | 2 |
| Barnes, JM | 1 |
| Ezdinli, EZ | 2 |
| Berard, CW | 2 |
| Orlow, EL | 1 |
| Bennett, JM | 3 |
| Gelmann, E | 1 |
| Anderson, T | 3 |
| Jaffe, E | 1 |
| Broder, S | 1 |
| Izzi, T | 1 |
| Porcellini, A | 1 |
| Delfini, C | 1 |
| Lucarelli, G | 1 |
| Somoza, N | 3 |
| Pavlovsky, S | 4 |
| Suárez, A | 3 |
| Morgenfeld, M | 1 |
| Besuschio, SC | 1 |
| Bezares, R | 1 |
| Quiroga Micheo, E | 1 |
| Lein, JM | 2 |
| De María, H | 2 |
| Andersen, E | 1 |
| Videbaek, A | 1 |
| Golomb, HM | 1 |
| Sweet, DL | 2 |
| Kuo, HC | 1 |
| Chou, CY | 1 |
| Chang, CH | 1 |
| Liu, MT | 1 |
| Tzeng, CC | 1 |
| Huang, KE | 1 |
| Chan, T | 1 |
| Juneja, S | 1 |
| Wolf, M | 1 |
| Januszewicz, E | 1 |
| Cooper, I | 1 |
| Tobinai, K | 2 |
| Watkins, SM | 1 |
| Freilich, RJ | 1 |
| Monjour, A | 1 |
| Jensen, MK | 1 |
| Pulczynski, S | 1 |
| Johansen, P | 1 |
| Meurman, JH | 1 |
| Laine, P | 1 |
| Keinànen, S | 1 |
| Pyrhönen, S | 1 |
| Teerenhovi, L | 1 |
| Lindqvist, C | 1 |
| Maeda, Y | 1 |
| Matsumoto, K | 1 |
| Kuriyama, M | 1 |
| Ono, Y | 1 |
| Kunishio, K | 1 |
| Tamiya, T | 1 |
| Furuta, T | 1 |
| Ohmoto, T | 1 |
| Bairey, O | 1 |
| Gabbay, U | 1 |
| Blickstein, D | 1 |
| Stark, P | 1 |
| Prokocimer, M | 1 |
| Epstein, O | 1 |
| Shaklai, M | 1 |
| Lahav, J | 1 |
| Alpaslan, G | 1 |
| Alpaslan, C | 1 |
| Gögen, H | 1 |
| Oğuz, A | 1 |
| Cetiner, S | 1 |
| Karadeniz, C | 1 |
| Wu, HG | 1 |
| Kim, IH | 1 |
| Ha, SW | 1 |
| Park, CI | 1 |
| Bang, YJ | 1 |
| Huh, DS | 1 |
| Herrlinger, U | 1 |
| Brugger, W | 1 |
| Bamberg, M | 1 |
| Küker, W | 1 |
| Dichgans, J | 1 |
| Weller, M | 1 |
| Dell'Oro, S | 1 |
| Ciceri, F | 1 |
| Bernardi, M | 1 |
| Camba, L | 1 |
| Ponzoni, M | 1 |
| Terreni, MR | 1 |
| Tomirotti, M | 1 |
| Spina, M | 1 |
| Kochi, M | 1 |
| Ushio, Y | 1 |
| Vettore, L | 1 |
| Pizzolo, G | 1 |
| Bakemeier, RF | 1 |
| Carbone, PP | 5 |
| Ezdinli, E | 2 |
| Lenhard, RE | 2 |
| Barduagni, A | 1 |
| Marolla, A | 1 |
| Calabresi, F | 1 |
| Terzoli, E | 1 |
| Bender, RA | 1 |
| Norton, L | 1 |
| Coltman, CA | 1 |
| Luce, JK | 1 |
| McKelvey, EM | 1 |
| Jones, SE | 1 |
| Moon, TE | 1 |
| Johnson, GJ | 1 |
| Pocock, SJ | 1 |
| Takácsi-Nagy, L | 1 |
| Tarkovács, G | 1 |
| Szende, B | 1 |
| Gráf, F | 1 |
| Fujimoto, S | 1 |
| Inagaki, J | 2 |
| Fleischer, J | 1 |
| Sutow, WW | 1 |
| Sullivan, MP | 1 |
| Carl, W | 1 |
| Sieber, SM | 1 |
| Tigges, FJ | 1 |
| Schmülling, RM | 1 |
| Hiller, E | 2 |
| Waller, HD | 1 |
| Wilms, K | 1 |
| Rubio-Félix, D | 1 |
| Maicas, M | 1 |
| Rubio-Vitaller, A | 1 |
| Gil, JL | 1 |
| Giralt, M | 1 |
| Raichs, A | 1 |
| Hartwich, G | 1 |
| Neidhardt, B | 1 |
| Brücher, H | 1 |
| Kluin-Neleman, JC | 1 |
| Neleman, FA | 1 |
| Meuwissen, OJ | 1 |
| Maes, RA | 1 |
| Cebrian-Bonesana, A | 1 |
| Schvartzman, E | 1 |
| Roca-Garcia, C | 1 |
| Pependieck, C | 1 |
| Sackmann-Muriel, S | 1 |
| Ojeda, FG | 1 |
| Kvicala, R | 1 |
| Penchansky, L | 1 |
| Morgenfeld, MC | 2 |
| Magnasco, J | 1 |
| Cavagnaro, FJ | 1 |
| Saslavsky, J | 1 |
| Macchi, A | 1 |
| Neretto, G | 1 |
| Giovanelli, E | 1 |
| Agricola, R | 1 |
| Furno, F | 1 |
| Roth, A | 1 |
| Cerlek, S | 1 |
| Dominis, M | 1 |
| Kolarić, K | 1 |
| Wright, SE | 1 |
| Buckner, CD | 1 |
| Clift, RA | 1 |
| Fefer, A | 1 |
| Storb, R | 1 |
| Klein, HO | 1 |
| Zittoun, R | 1 |
| Barthélémy, M | 1 |
| Bouchard, M | 1 |
| Blanc, CM | 1 |
| Bousser, J | 1 |
| Bilski-Pasquier, G | 1 |
| Maj, S | 1 |
| Leszko, B | 1 |
| Lewicka, T | 1 |
| Janowska-Wieczorek, A | 1 |
| Sobczyńska, Z | 1 |
| Pawelski, S | 1 |
| Roth, DG | 1 |
| Desser, RK | 1 |
| Miller, JB | 1 |
| Ultmann, JE | 2 |
| Roth, Z | 1 |
| Kitazima, K | 1 |
| Yamada, O | 1 |
| Koresawa, S | 1 |
| Yawata, Y | 1 |
| Shibata, S | 1 |
| Viollier, AF | 1 |
| Senn, HJ | 1 |
| Bláha, M | 1 |
| Vanásek, J | 1 |
| Mazák, J | 1 |
| Matĕja, F | 1 |
| Stutzman, L | 2 |
| Pavlovsky, A | 1 |
| Palau, M | 1 |
| Barros, CA | 1 |
| Schein, PS | 3 |
| Canellos, GP | 5 |
| Young, RD | 1 |
| Berard, C | 2 |
| Durant, JR | 2 |
| Loeb, V | 1 |
| Dorfman, R | 1 |
| Chan, YK | 1 |
| Sahakian, GJ | 1 |
| Ihde, DC | 3 |
| Thumb, N | 1 |
| Reed, DJ | 1 |
| Levy, LM | 1 |
| Sonqishe, M | 1 |
| Solidoro, A | 1 |
| Payet, C | 1 |
| Sanchez-Lihon, J | 1 |
| Montalbetti, JA | 1 |
| Arai, N | 2 |
| Hara, A | 2 |
| Umeda, M | 2 |
| Shirai, T | 2 |
| Hsu, JR | 1 |
| Chang, SC | 1 |
| Perng, RP | 1 |
| Goldman, DL | 1 |
| Dahlborg, SA | 1 |
| Crossen, J | 1 |
| Ramsey, F | 1 |
| Roman-Goldstein, S | 1 |
| Braziel, R | 1 |
| Dana, B | 1 |
| Li, XJ | 1 |
| Zhao, BL | 1 |
| Hou, JW | 1 |
| Xin, WJ | 1 |
| Xie, RF | 1 |
| Chen, YR | 1 |
| Shirakawa, S | 1 |
| Tanaka, I | 1 |
| Kita, K | 1 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Bron, D | 1 |
| Vandenheule, B | 1 |
| Stryckmans, P | 1 |
| Bonadonna, G | 2 |
| Armitage, JO | 1 |
| Weisenburger, DD | 1 |
| Hutchins, M | 1 |
| Moravec, DF | 1 |
| Dowling, M | 1 |
| Sorensen, S | 1 |
| Mailliard, J | 1 |
| Okerbloom, J | 1 |
| Johnson, PS | 1 |
| Howe, D | 1 |
| Gerhartz, HH | 1 |
| Nerl, C | 1 |
| Wilmanns, W | 2 |
| Huhn, D | 1 |
| Lawlor, E | 1 |
| O'Briain, DS | 1 |
| Finn, T | 1 |
| Ward, R | 1 |
| Rogers, FM | 1 |
| O'Brien, AA | 1 |
| Daly, PA | 1 |
| Boyd, DB | 2 |
| Papish, SW | 1 |
| Topilow, A | 1 |
| Kopel, SK | 1 |
| Bernhardt, B | 1 |
| Files, JC | 1 |
| Schwartz, S | 1 |
| Gaynor, M | 1 |
| McDermott, D | 1 |
| Straus, DJ | 1 |
| Ohnishi, K | 1 |
| Hotta, T | 1 |
| Murate, T | 1 |
| Inoue, C | 1 |
| Ichikawa, A | 1 |
| Ninomiya, N | 1 |
| Goto, S | 1 |
| Tsushita, K | 1 |
| Utsumi, M | 1 |
| Nagura, E | 1 |
| Akiyoshi, T | 1 |
| Kimura, N | 1 |
| Hisano, S | 1 |
| Kawara, T | 1 |
| Morioka, E | 1 |
| Ishibashi, M | 1 |
| Kyoshoin, K | 1 |
| Kikuchi, M | 1 |
| Okumura, M | 1 |
| Longo, D | 1 |
| Kobayashi, Y | 1 |
| Yasunaga, Y | 1 |
| Yoshioka, T | 1 |
| Matsuda, M | 1 |
| Oritani, K | 1 |
| Kuyama, J | 1 |
| Ohnishi, S | 1 |
| Tada, Y | 1 |
| Miyagawa, M | 1 |
| Ohnoshi, T | 1 |
| Hayashi, K | 1 |
| Ueno, K | 1 |
| Tada, A | 1 |
| Murashima, M | 1 |
| Mizuta, J | 1 |
| Tagawa, S | 1 |
| Kimura, I | 1 |
| Duffey, PL | 1 |
| Jaffe, ES | 1 |
| Gilliom, M | 1 |
| Maekawa, I | 1 |
| Kawamura, T | 1 |
| Miyake, T | 1 |
| Love, RR | 1 |
| Leventhal, H | 1 |
| Easterling, DV | 1 |
| Nerenz, DR | 1 |
| Hermes, C | 1 |
| Daus, H | 1 |
| Köhler, M | 1 |
| Mauch, H | 1 |
| Scheurlen, PG | 1 |
| Kanda, H | 1 |
| Hachisuka, K | 1 |
| Yamaguchi, A | 1 |
| Isogai, M | 1 |
| Kato, J | 1 |
| Matsushita, M | 1 |
| Oda, T | 1 |
| Harakawa, I | 1 |
| Kuze, S | 1 |
| Mayumi, T | 1 |
| De Vita, VT | 2 |
| Shimada, Y | 1 |
| Nagai, M | 1 |
| Irino, S | 1 |
| Uda, H | 1 |
| Eridani, S | 1 |
| Singh, AK | 1 |
| Hautekeete, ML | 1 |
| Berneman, ZN | 1 |
| Bieger, R | 1 |
| Stevens, WJ | 1 |
| Bridts, C | 1 |
| Buyssens, N | 1 |
| Peetermans, ME | 1 |
| Asada, E | 1 |
| Koide, M | 1 |
| Kato, H | 1 |
| Kobayashi, I | 1 |
| Hasegawa, G | 1 |
| Toner, GC | 1 |
| Sinclair, RA | 1 |
| Sutherland, RC | 1 |
| Schwarz, MA | 1 |
| Schreiber, DP | 1 |
| Jacobs, C | 1 |
| Rosenberg, SA | 2 |
| Cox, RS | 1 |
| Hoppe, RT | 1 |
| Perri, RT | 1 |
| Allen, JI | 1 |
| Oken, MM | 1 |
| Limas, C | 1 |
| Kay, NE | 1 |
| Anderson, JR | 2 |
| Melvin, F | 1 |
| Davis, TE | 1 |
| O'Connell, MJ | 1 |
| Stacher, A | 1 |
| Binsack, T | 1 |
| Sauer, H | 1 |
| Steward, WP | 1 |
| Harris, M | 1 |
| Wagstaff, J | 1 |
| Deakin, DP | 1 |
| Crowther, D | 1 |
| Frei, E | 1 |
| Nakajima, H | 1 |
| Miyamoto, H | 1 |
| Kaplan, HS | 1 |
| Johnson, DH | 1 |
| Linde, R | 1 |
| Hainsworth, JD | 1 |
| Vale, W | 1 |
| Rivier, J | 1 |
| Stein, R | 1 |
| Flexner, J | 1 |
| Van Welch, R | 1 |
| Greco, FA | 1 |
| Song, SZ | 1 |
| Rusthoven, JJ | 1 |
| MacKenzie, R | 1 |
| Jenkin, RD | 1 |
| Chilcote, RR | 1 |
| Coccia, P | 1 |
| Exelby, P | 1 |
| Kersey, J | 1 |
| Kjeldsberg, CR | 1 |
| Kushner, J | 1 |
| Meadows, AT | 1 |
| Siegel, S | 1 |
| King, DJ | 1 |
| Ratcliffe, MA | 1 |
| Dawson, AA | 1 |
| Bennett, B | 1 |
| Macgregor, JE | 1 |
| Klopper, AI | 1 |
| Rudders, RA | 1 |
| Flexner, JM | 1 |
| Gleichmann, E | 1 |
| Gleichmann, H | 1 |
| Weiss, HD | 1 |
| Walker, MD | 1 |
| Wiernik, PH | 1 |
| Sage, RE | 1 |
| De Lena, M | 1 |
| Banfi, A | 1 |
| Lattuada, A | 1 |
| Hamlin, JA | 1 |
| Kagan, AR | 1 |
| Friedman, NB | 1 |
| Nissen, NI | 1 |
| Walbom-Jorgensen, S | 1 |
| Lawhorn, TI | 1 |
| Stone, HH | 1 |
| Martin, JD | 1 |
| Trueblood, HW | 1 |
| Guernsey, JM | 1 |
| Cohn, R | 1 |
| Matsumoto, N | 1 |
| Oyama, H | 1 |
| Matsumura, M | 1 |
| Suetsugu, N | 1 |
| Abe, S | 1 |
| Rubin, P | 1 |
| Rodriguez, V | 2 |
| Bodey, GP | 1 |
| Gociu, M | 1 |
| Schein, PJ | 1 |
| Aungst, CW | 1 |
| Knospe, WH | 1 |
| Fairley, GH | 2 |
| Freeman, JE | 1 |
| Gutterman, J | 1 |
| Brunning, RD | 1 |
| Lessner, HE | 1 |
| Shimoyama, M | 1 |
| Kitahara, T | 1 |
| Sakano, T | 1 |
| Konda, C | 1 |
| Sakai, Y | 1 |
| Jencks, JA | 1 |
| Binder, RA | 1 |
| McElwain, TJ | 1 |
| Morrone, G | 1 |
| Kurnick, JE | 1 |
| Robinson, WA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Combined Immunochemotherapy Followed by Reduced Dose RT for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma[NCT00594815] | 52 participants (Actual) | Interventional | 2002-08-28 | Completed | |||
| Multicenter Randomized Phase II Study of Methotrexate (MTX) and Temozolomide Versus MTX, Procarbazine, Vincristine and Cytarabine for Primary CNS Lymphoma (PCNSL) in the Elderly[NCT00503594] | Phase 2 | 92 participants (Anticipated) | Interventional | 2007-07-31 | Recruiting | ||
| A Phase II， Single-arm Trail of Chidamide Combined With Rituximab and High-dose Methotrexate in Previously Untreated Patients With Primary Central Nervous System Lymphoma[NCT04516655] | Phase 2 | 51 participants (Anticipated) | Interventional | 2020-09-01 | Not yet recruiting | ||
| Phase Ⅱ Trial of Temozolomide Plus Concurrent Whole-Brain Radiation Followed by TNV Regimen as Adjuvant Therapy for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma (PCNSL)[NCT01735747] | Phase 2 | 16 participants (Anticipated) | Interventional | 2008-06-30 | Active, not recruiting | ||
| Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma :a Phase II, Single-arm, Open-label, Muti-center Study[NCT02879526] | Phase 2 | 45 participants (Anticipated) | Interventional | 2016-08-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Overall Progression Free Survival at 2 years (NCT00594815)
Timeframe: 2 Years
| Intervention | percentage of participants (Number) |
|---|---|
| Immunocompetent Pts With Newly Diagnosed Primary CNS Lymphoma | 57 |
The toxicity of this combined regimen will be measured using the NCI CTC version 2.0. (NCT00594815)
Timeframe: 2 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Immunocompetent Pts With Newly Diagnosed Primary CNS Lymphoma | 52 |
35 reviews available for procarbazine and Germinoblastoma
| Article | Year |
|---|---|
The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxor | 1984 |
"Good risk" non-Hodgkin lymphomas: approaches to management.
Topics: Actuarial Analysis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1983 |
[Therapy of malignant lymphomas].
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, | 1983 |
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1984 |
[Malignant lymphoma].
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disea | 1981 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyt | 1995 |
[Recent progress in the chemotherapy of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 1995 |
[Chemo-radiotherapy for malignant brain tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Central Nervous System | 2002 |
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Ad | 1977 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; | 1977 |
[Chemotherapy of malignant lymphomas].
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Neoplasm | 1978 |
[Chemotherapy of malignant lymphomas].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cyclophosphamide; Drug Combinations; Hodgkin Dis | 1978 |
Human models of human diseases; breast cancer and the lymphomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; | 1979 |
Current status of treatment of lymphomas.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Therapy, Combin | 1975 |
Advances in lymphoma treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Forecasting; Humans; Im | 1992 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethaso | 1985 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1985 |
[Drug therapy of malignant lymphoma].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1985 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
[Current status of chemotherapy in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphoma; Mechlore | 1987 |
[Advances in the chemotherapy of non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality The | 1985 |
Early-stage Hodgkin's disease: current approaches to treatment.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem | 1985 |
Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.
Topics: Animals; Animals, Newborn; Antilymphocyte Serum; Antimetabolites; Azathioprine; Carcinogens; Cell Di | 1973 |
Neurotoxicity of commonly used antineoplastic agents (second of two parts).
Topics: Achilles Tendon; Animals; Antineoplastic Agents; Autonomic Nervous System; Central Nervous System Di | 1974 |
Chemotherapy in solid tumors of childhood.
Topics: Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Eye Neopla | 1972 |
Hodgkin's disease and non-Hodgkin's lymphoma--the surgeon's role in therapy.
Topics: Adolescent; Adult; Alkylating Agents; Child; Female; Hodgkin Disease; Humans; Laparotomy; Lymphoma; | 1972 |
Non-Hodgkin's lymphoma: recent observations on natural history and intensive treatment.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Follow-Up Studies; Humans; Lymphoma; Lymp | 1972 |
Combination chemotherapy for lymphomas and leukemias.
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgk | 1973 |
Management of malignant lymphomas.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cel | 1973 |
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Dru | 1972 |
Malignant lymphoma. 2. Therapy.
Topics: Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Nitrogen | 1974 |
[Cytostatic chemotherapy of neoplasms in children].
Topics: Adrenal Cortex Hormones; Aminopterin; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; | 1971 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin | 1971 |
33 trials available for procarbazine and Germinoblastoma
| Article | Year |
|---|---|
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.
Topics: Aged; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Procarbazine; Quality of Life; Ritu | 2023 |
A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine.
Topics: Aftercare; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemora | 2017 |
Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Brain Neoplasms; Disease-Fr | 2014 |
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Comb | 2015 |
Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2016 |
Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Cyclophosphamide; Dog Diseases; | 2010 |
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Biops | 2003 |
Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neop | 2005 |
Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms | 2005 |
Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cognition; Combined Modality | 2005 |
Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2007 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combi | 2007 |
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Respons | 2008 |
Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Proto | 1984 |
A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin | 1981 |
Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy.
Topics: Adult; Aged; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Dose-Response Relationship, Dru | 1981 |
Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cent | 1996 |
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous | 1999 |
PCV salvage chemotherapy for recurrent primary CNS lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Huma | 2000 |
Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
Topics: Bleomycin; Carmustine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug T | 1976 |
Combined therapy with bleomycin and some immunological implications.
Topics: Adolescent; Adult; Bleomycin; Cell Division; Clinical Trials as Topic; Drug Administration Schedule; | 1976 |
Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; | 1977 |
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
Topics: Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration | 1977 |
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Ad | 1977 |
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Topics: Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combinatio | 1979 |
Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat | 1978 |
[Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)].
Topics: Androgens; Anemia; Antineoplastic Agents; Drug Therapy, Combination; Humans; Lymphoma; Mechlorethami | 1977 |
[Comparison of CHOP and COP-BLAM chemotherapy in highly malignant non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 1986 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Follow-Up Stud | 1985 |
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine | 1985 |
The treatment of diffuse undifferentiated non-Hodgkin's lymphoma in children: the Childrens Cancer Study Group experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Clinical | 1985 |
159 other studies available for procarbazine and Germinoblastoma
| Article | Year |
|---|---|
Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Hypercalcemia; Lomustin | 2022 |
Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxor | 2022 |
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2022 |
Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Huma | 2023 |
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Doxorubicin; Lymphoma; | 2023 |
Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Lymphoma; Mechlorethami | 2020 |
Which regimen is better for stem cell mobilization of lymphoma patients?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deox | 2013 |
Procarbazine and antidepressants: a retrospective review of the risk of serotonin toxicity.
Topics: Antidepressive Agents; Antineoplastic Agents; Drug Interactions; Female; Humans; Lymphoma; Male; Mid | 2014 |
Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplast | 2015 |
Fifty years from Paris: the remarkable story of the lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Congresses as Topic; History, 19th Century; History, | 2015 |
[Efficacy of R±BEACOP regimen in patients with
poor-prognosis lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 2015 |
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combine | 2016 |
Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
Topics: Biomarkers; Child, Preschool; Cyclophosphamide; Female; Fertility; Follicle Stimulating Hormone; Fol | 2009 |
Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; | 2009 |
Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System | 2011 |
A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma.
Topics: Aged; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neopla | 2010 |
Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neo | 2011 |
Prophylactic intrathecal chemotherapy in primary CNS lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 2012 |
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Drug Resistance, Neopla | 2011 |
Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Endothelial Cells; Etoposide; Ge | 2012 |
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth | 2003 |
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2002 |
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2002 |
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2002 |
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2002 |
[TRIAL THERAPY OF HODGKIN'S DISEASE AND OTHER LYMPHOMAS WITH METHLHYDRAZINE. P-(N'-METHYLHTDRAZINOMETHLY)-N-ISOPROPYL-BENZMIDE HCL (NATULAN)].
Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Procarbazine | 1964 |
NATULAN IN MANAGEMENT OF LATE HODGKIN'S DISEASE, OTHER LYMPHORETICULAR NEOPLASMS, AND MALIGNANT MELANOMA.
Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Lymphoma, Follic | 1965 |
[RESULTS OF CLINICAL TESTS OF A NEW CYTOSTATIC SUBSTANCE FROM THE METHYLHYDRAZINE SERIES (NATULAN)].
Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Humans; Hydrazines; Leukemia; Leukemia, Lympho | 1965 |
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Centra | 2005 |
Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2006 |
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2007 |
Results of treatment of 112 cases of primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2008 |
Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; B | 1984 |
Therapy of non-Hodgkin's lymphomas in relapse.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Imidazoles; Lymphoma; Neoplasm Recurrence, Loca | 1980 |
Management of the indolent non-Hodgkin's lymphomas.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1980 |
[Chemotherapy of non-Hodgkin lymphoma with poor prognosis].
Topics: Antineoplastic Agents; Asparaginase; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Ther | 1980 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cyclophosph | 1982 |
[Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
[Clinical aspects and therapy of anaplastic T-zone lymphoma].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; | 1984 |
Adult-type systemic varicella in a female patient in course of treatment of her so-called reactive lymphocytic (T-cell) hyperplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Connective Tissue; Cyclophosphami | 1984 |
Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; | 1983 |
Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modali | 1984 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1984 |
[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hum | 1984 |
Acute oliguric renal failure secondary to lymphomatous infiltration of the kidneys.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Kidney Neoplasms; | 1984 |
Poor prognosis non-Hodgkin's lymphoma in the elderly: clinical presentation and management.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cyclo | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
[Therapeutic results of 36 malignant lymphomas and 8 histiocytic medullary reticulosis in childhood].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1984 |
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bloo | 1983 |
[Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxo | 1983 |
Treatment of non Hodgkin's lymphoma with "PROVECIP" (procarbazine, vinblastine, cyclophosphamide and prednisone).
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Femal | 1980 |
[Chemotherapy of non-Hodgkin lymphomas].
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Drug Therapy, Combination; Humans; Leukemia, Hairy | 1980 |
Pretreatment nausea in cancer chemotherapy: a conditioned response?
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Conditioning, Psycholo | 1980 |
[Advantages of thoracic CT scanning in the treatment of mediastinal lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphoma; Mechlorethamine | 1982 |
Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin | 1982 |
[Therapeutic results in malignant lymphomas treated by the COPP and POPP drug administration schedules].
Topics: 4-Aminobenzoic Acid; Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; D | 1981 |
[Chemotherapy of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; | 1982 |
Deferral of initial therapy for advanced indolent lymphomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therap | 1982 |
Role of combined-modality therapy in the curative management of advanced-stage "favorable" non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Therapy, Combination; Humans; | 1982 |
Chemotherapy for lymphoma in a patient with common variable immunodeficiency: case report, literature review, and recommendations for chemotherapy in immunodeficient patients.
Topics: Adult; Agammaglobulinemia; Aged; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Fema | 1982 |
[Therapy of non-Hodgkin lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Humans; | 1982 |
Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubici | 1981 |
Procarbazine-induced skin reactions in Hodgkin's disease and other malignant lymphomas.
Topics: Drug Hypersensitivity; Hodgkin Disease; Humans; Lymphoma; Procarbazine; Urticaria | 1980 |
Diagnosis, staging, and treatment of the malignant lymphomas.
Topics: Biopsy; Cyclophosphamide; Drug Combinations; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Mechlor | 1980 |
Primary malignant lymphoma of the uterine cervix shows favorable response to neoadjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosp | 1994 |
Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1994 |
Predicting neutropenia after chemotherapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cy | 1993 |
Suspected malignant lymphoma presenting with widespread granulomatous lesions in bones and lymph nodes and responding to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Chlorambucil; Diagnosis, Differentia | 1996 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Ch | 1997 |
[Clinical study of primary central nervous system lymphoma: the role of chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 1997 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherap | 1997 |
Disturbances in oral and dental structures in patients with pediatric lymphoma after chemotherapy: a preliminary report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Case-Control St | 1999 |
Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Comb | 2001 |
[Criteria for choice of therapeutic procedures in lymphomas].
Topics: Antineoplastic Agents; Bleomycin; Cobalt Radioisotopes; Doxorubicin; Drug Therapy, Combination; Hodg | 1975 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Com | 1977 |
A clinicopathological study of non-Hodgkin's malignant lymphomas in terms of the Kiel classification.
Topics: Bone Marrow Examination; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Neoplasm Sta | 1978 |
Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration | 1979 |
[Therapy of non-Hodgkin lymphomas].
Topics: Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Mustard Compo | 1979 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combinatio | 1976 |
Cancer chemotherapy and dentistry.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Asparaginase; Carci | 1977 |
[Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)].
Topics: Adult; Cyclophosphamide; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Dif | 1977 |
[Therapy of non-Hodgkin lymphomas with COP and COPP regimens (author's transl)].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Larg | 1977 |
[Comparative study of two drug combination in non-Hodgkin's lymphoma (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combinati | 1978 |
[Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine | 1978 |
Liver changes induced by cytostatic drugs in patients with non Hodgkin's lymphomas.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Female; Hepatitis; Humans; Liver; Liver Neoplasms; L | 1978 |
Experience with second marrow transplants.
Topics: Anemia, Aplastic; Bone Marrow Cells; Bone Marrow Transplantation; Cyclophosphamide; Graft Rejection; | 1976 |
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphom | 1976 |
[Combined treatment of malignant lymphoma].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Humans; Lymphoma; Nitrogen Mustard Compounds; Pred | 1977 |
Avascular necrosis of the femoral head with combination therapy.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Female; Femur Head; Femur Head Necrosis; Hodgkin Dis | 1976 |
Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Male; N | 1976 |
[A modified MOPP therapy on advanced malignant lymphoma (author's transl)].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma; Male | 1976 |
[Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Topics: Agranulocytosis; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Life | 1976 |
Experience in the treatment of malignant lymphomas.
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Nitrogen Must | 1976 |
Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Femal | 1975 |
Results of combination chemotherapy of non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Larg | 1975 |
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Lar | 1975 |
Management of Hodgkin's and non-Hodgkin's lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1975 |
Osteonecrosis of the femoral head in patients with lymphoma treated with intermittent combination chemotherapy (including corticosteroids).
Topics: Adrenal Cortex Hormones; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Drug Therapy, Combin | 1975 |
[Side effects in immunosuppressive therapy].
Topics: Alopecia; Amenorrhea; Anemia; Azathioprine; Bacterial Infections; Chlorambucil; Female; Humans; Immu | 1975 |
Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Pos | 1976 |
Effects in vivo of lymphoma ascites tumors and procarbazine, alone and in combination, upon hepatic drug- metabolizing enzymes of mice.
Topics: Aniline Hydroxylase; Animals; Cell Line; Cytochrome P-450 Enzyme System; Ethylmorphine-N-Demethylase | 1976 |
Gastric lymphomas: chemotherapy as a primary treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1990 |
[The COP-BLAM therapy for malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 1990 |
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Daca | 1990 |
[Salvage chemotherapy with IMV-triple P for relapsed or refractory malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Female; Hea | 1991 |
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cogniti | 1991 |
Active oxygen radicals produced by leukocytes of malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Electron Spin Resonan | 1990 |
[Malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1985 |
Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamid | 1986 |
Hematologic malignancies: non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 1986 |
The simultaneous presentation of peripheral T-cell lymphoma and hairy cell leukemia.
Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Antineoplastic C | 1987 |
COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 1988 |
Infusions, age, and drug doses: redux.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1988 |
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Femal | 1989 |
[Secondary leukemia (AML) with TcR beta rearrangement].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Female; Gene Rearra | 1989 |
ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 1985 |
[Triple malignancy including bladder carcinoma, prostate carcinoma and malignant lymphoma: a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; | 1989 |
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1989 |
[Adult T-cell leukemia and non-Hodgkin's lymphoma in brothers].
Topics: Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Deltaretrovirus Antibodies; Doxor | 1986 |
Side effects and emotional distress during cancer chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxor | 1989 |
[Transitory oligoclonal paraproteinemia with virus infection and malignant lymphatic disease].
Topics: Agammaglobulinemia; Aged; Cytomegalovirus Infections; Female; Humans; Immunoglobulin A; Immunoglobul | 1985 |
[Treatment of primary gastric lymphoma and factors that influence the prognosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1988 |
[A case of primary malignant lymphoma of the prostate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma; Male; Middle Age | 1987 |
Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Hodgkin Disease; Humans; Immun | 1986 |
Purpura fulminans in pneumococcal sepsis.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Fema | 1986 |
[Pregnancy following chemotherapy of non-Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1986 |
Composite lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans | 1986 |
The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Female; Hod | 1985 |
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
[Cytostatic polychemotherapy in the aged].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dac | 1985 |
A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Female; Gast | 1985 |
Current status and new vistas in combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
[Malignant lymphoma of the skin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Diagnos | 1985 |
Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Fertil | 1985 |
Fertility in young men and women after treatment for lymphoma: a study of a population.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fertility; Follicle Stimu | 1985 |
Treatment of the lymphomas.
Topics: Bleomycin; Burkitt Lymphoma; Drug Synergism; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Ce | 1972 |
Treatment of advanced malignant lymphomas with bleomycin.
Topics: Antibiotics, Antineoplastic; Bleomycin; Cyclophosphamide; Drug Combinations; Hodgkin Disease; Humans | 1972 |
Management of malignant lymphomas: a practical and philosophical approach.
Topics: Bleomycin; Cyclophosphamide; Hodgkin Disease; Hospitals, Special; Humans; Laparotomy; Lymphoma; Mech | 1973 |
Chemotherapy of lymphomas.
Topics: Alkylating Agents; Child; Drug Therapy, Combination; Humans; Lymphoma; Procarbazine; Vinca Alkaloids | 1974 |
Secondary neoplasms in malignant lymphomas after intensive therapy.
Topics: Adult; Antineoplastic Agents; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; | 1973 |
Lymphomas of the testicle.
Topics: Adult; Aged; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Large B-Cel | 1972 |
[Hodgkin's disease and other malignant lymphomas].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednison | 1972 |
[Treatment of malignant lymphoma with procarbazine].
Topics: Adult; Antineoplastic Agents; Benzoates; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, | 1972 |
Management of patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Ly | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymp | 1974 |
Treatment of Hodgkin's disease and other malignant lymphomas.
Topics: Alkylating Agents; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; | 1973 |
Blood and neoplastic diseases. Treatment of the lymphomas.
Topics: Alopecia; Bone Marrow; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Ne | 1974 |
Combination chemotherapy of advanced lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Female; Hodgkin Disease; Human | 1972 |
Combination chemotherapy for patients with malignant lymphoma.
Topics: Antineoplastic Agents; Drug Combinations; Follow-Up Studies; Humans; Lymphoma; Mechlorethamine; Pred | 1972 |
The effects of leukemia and lymphoma chemotherapy on hematopoietic cells.
Topics: Alkylating Agents; Antimetabolites; Antineoplastic Agents; Asparaginase; Cell Division; Daunorubicin | 1973 |
Current concepts in treatment of lymphomas with special reference to Hodgkin's disease.
Topics: Age Factors; Hodgkin Disease; Humans; Hyperplasia; Lymphoma; Procarbazine; Sex Factors; Steroids; Ti | 1973 |
Development of four-drug BCNU combination chemotherapy regimens.
Topics: Carmustine; Cyclophosphamide; Evaluation Studies as Topic; Hematologic Diseases; Hodgkin Disease; Hu | 1973 |
[Clinical experience with procarbazine in malignant lymphomas--single and combination (VENP) therapy].
Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Humans; Lymphoma; Prednisolone; Procarbazine; Vi | 1973 |
The nitroblue tetrazolium (NBT) dye test in determining fever source in lymphoma.
Topics: Bacterial Infections; Diagnosis, Differential; Evaluation Studies as Topic; False Positive Reactions | 1974 |
Chemotherapy of the lymphomas.
Topics: Adult; Burkitt Lymphoma; Child; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1974 |
Current concepts in the management of lymphoma.
Topics: Adolescent; Adult; Age Factors; Drug Synergism; Hepatomegaly; Hodgkin Disease; Humans; Immunologic D | 1971 |
Combination chemotherapy of advanced lymphomas.
Topics: Adult; Age Factors; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Drug Combination | 1972 |